DJIA 16,963.26 43.67 0.26%
NASDAQ 4,526.58 -0.93 -0.02%
S&P 500 1,985.03 3.43 0.17%
market minute promo

54.81 -0.49 (-0.89%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

LGND $54.81 -0.89%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $55.10
Previous Close $55.30
Daily Range $54.60 - $55.74
52-Week Range $39.75 - $80.42
Market Cap $1.1B
P/E Ratio 153.61
Dividend (Yield) $0.00 (0.0%)
Volume 245,442
Average Daily Volume 482,466
Current FY EPS $1.05

Sector

Healthcare

Industry

Drugs

Ligand Pharmaceuticals, Inc. (LGND) Description

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases. Website: http://www.ligand.com/

News & Commentary Rss Feed

3 Stocks That Soared Stupendously This Week

Double-digit gains in a shortened trading week? Here's how these 3 stocks did it.

Ligand Up on Multi-Program Captisol Deal with Avion Pharma - Analyst Blog

Insider Trading Alert - LGND, BRCM And TER Traded By Insiders

UPDATE: Avion Pharma Reports Signing of Commercial License Deal with Ligand Pharma for Development,

UPDATE: Avion Pharma Reports Signing of Commercial License Deal with Ligand Pharma for Development, Commercialization of Four Captisol-Enabled Programs, Ligand Entitled to Upfront Payment

Update: Ligand's New License Agreement Strengthens Portfolio

Stocks To Watch For August 12, 2014

Ligand Gains on Q2 Earnings Beat, Increases Guidance - Analyst Blog

Exclusive: Emmanuel Lemelson Talks Ligand Pharmaceuticals

Ligand Pharmaceuticals (LGND) Jumps: Stock Up 10.1% - Tale of the Tape

Ligand Pharmaceuticals Reports Earnings; Lemelson Capital Adds To Short Position

Update: Ligand Earnings - Strong Q2-Growth Beats Expectations

See More LGND News...

LGND's Top Competitors

LGND $54.81 (-0.89%)
Current stock: LGND
AMGN $132.40 (-0.47%)
Current stock: AMGN
GILD $101.12 (-0.16%)
Current stock: GILD
BIIB $342.67 (-0.92%)
Current stock: BIIB